Indications: neuroses and neurotic disorders; heartburns of various origin, which are not related to coronary heart disease; for the improvement of tolerability of neuroleptics and tranquilisers; in complex therapy to reduce the craving for smoking.
An anxiolytic agent. In terms of chemical structure, mebicar is similar to natural body metabolites. It does not interact with acids, alkali, oxidants or reducing agents, various medications or food components. Mebicar affects all major neurotransmitter systems.
Adaptol® can be used without the need to interrupt work or studies, since it does not cause drowsiness, exalted mood or euphoria, it does not cause the development of dependency and addiction, abstinence syndrome.
300 – 500 mg 2-3 times per day. Duration of therapy lasts from a couple of days to 2 – 3 months.
A complex therapy for the reduction of the craving for smoking: 600 – 1,000 mg for 5 to 6 weeks.
Safety and efficacy of Adaptol® use in children under 18 years of age has not been proven.
See the summary of product characteristics for more detailed information.